Epigenetic Modulation in Kidney Injury Mechanisms

Epigenetic modulation encompasses heritable yet reversible alterations in gene expression that occur without changes to the underlying DNA sequence. In the context of kidney injury, these mechanisms orchestrate the balance between tissue repair and maladaptive responses leading to fibrosis, inflammation and chronic organ dysfunction. Key layers of epigenetic control include histone modifications such as acetylation and methylation, DNA methylation and the regulatory roles of non-coding RNAs. In acute kidney injury (AKI), dynamic remodelling of chromatin can determine tubular epithelial cell fate, modulating pathways of cell death, survival and inflammatory signalling. As AKI transitions to chronic kidney disease (CKD), sustained epigenetic marks may lock in profibrotic programmes, perpetuating extracellular matrix deposition and vascular rarefaction. Understanding these processes has revealed targets for therapeutic intervention, including selective inhibitors of histone-modifying enzymes, and holds promise for the development of epigenome-directed strategies to preserve renal function.

Research from Nature Portfolio

Recent studies have identified specific histone deacetylases that orchestrate epithelial cell cycle progression and fibrotic cascade in experimental models of renal injury. One investigation demonstrated that upregulation of HDAC9 in proximal tubular cells drives G2/M arrest, promoting profibrotic cytokine release and interstitial fibrosis; tubule-specific deletion or pharmacological blockade of HDAC9 attenuated cell cycle arrest, reduced matrix deposition and improved renal architecture in murine models.

Integrative epigenetic mapping has revealed distinct chromatin and transcriptional signatures that differentiate acute from chronic stages of kidney injury. By coupling multiplex gene expression analysis with targeted chromatin immunoprecipitation, researchers have characterised stage-specific epigenetic landscapes at key injury-associated loci, uncovering subsets of genes whose activation in AKI and CKD is governed by shared or divergent histone modification patterns, thereby identifying potential epigenetic biomarkers and intervention points.

A novel pan-histone deacetylase inhibitor was shown to confer renoprotection in obstructive nephropathy by suppressing TGF-β-driven fibrogenesis and inflammatory signalling. Treatment in a unilateral ureteral obstruction model attenuated tubular inflammation, reduced Smad2/3 phosphorylation and inhibited p38-MAPK activation, demonstrating that broad targeting of histone deacetylation can mitigate both fibrotic and immune-mediated pathways in kidney injury.

Epigenetic Modulation in Kidney Injury Mechanisms publication trend

The graph below shows the total number of articles in epigenetic modulation in kidney injury mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Histone deacetylases (HDACs): Enzymes that remove acetyl groups from lysine residues on histone proteins, leading to a more condensed chromatin state and transcriptional repression.

Histone acetylation: Addition of acetyl groups to histones, generally associated with chromatin relaxation and active gene transcription.

DNA methylation: Covalent addition of methyl groups to cytosine bases in DNA, often resulting in stable gene silencing.

Ferroptosis: A regulated form of cell death driven by iron-dependent lipid peroxidation, distinct from apoptosis and necrosis.

Autophagy: A cellular self-digestion process that degrades damaged organelles and proteins via lysosomal pathways, contributing to cell survival under stress.

Chromatin immunoprecipitation (ChIP): A method for analysing protein–DNA interactions and mapping histone modifications at specific genomic regions.

References

1. HDAC9-mediated epithelial cell cycle arrest in G2/M contributes to kidney fibrosis in male mice. Nature Communications (2023).
2. Distinct patterns of transcriptional and epigenetic alterations characterize acute and chronic kidney injury. Scientific Reports (2018).
3. Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease. Scientific Reports (2018).
4. VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury. Frontiers in Pharmacology (2023).
5. Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells. Cell Death & Disease (2018).
6. PSTPIP2 inhibits cisplatin-induced acute kidney injury by suppressing apoptosis of renal tubular epithelial cells. Cell Death & Disease (2020).